MarginsXMarginsX
Home › Canada › CSE stocks › FNT.U

FLUENT Corp. (CSE: FNT.U)

FNT.U trades on the Canadian Securities Exchange in Life Sciences. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 11, 2026
USD 0.0150
0.00% on the day
Market cap (C$)
Not shown: C$0.015 on 2026-11-11 times 31,712,435 shares is 0.0 times the US line FLNT's market cap
Market cap (US$)
No C$ cap to convert
1-year return
-72.7%
-70.0% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 13, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for FNT-U.CN, last bar 2026-11-11, computed by MarginsX. Website: sociallinks: 10-K text ("our website").

Profile

FieldValue
TickerFNT.U on the Canadian Securities Exchange
Yahoo symbolFNT-U.CN
SectorLife Sciences, Drug Manufacturers—Specialty & Generic
HeadquartersThe TMX list gives no head office
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstanding31,712,435
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0001460329
Websitewww.fluentco.com
US listingFLNT

Returns

WindowReturn
1 day0.0%
1 week0.0%
1 month-25.0%
3 months-25.0%
6 months-40.0%
Year to date-70.0%
1 year-72.7%
From 52-week high-76.9%
52-week rangeUSD 0.0150 to USD 0.0650

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

17 documents in 5 types. Each title links to the document at its source.

News release (1)

DocumentTypeFiled
Press release, dated November 12, 2026News release (8-K)2026-11-12

Quarterly report (1)

DocumentTypeFiled
FORM 10-Q
Period 2026-09-30
Quarterly report (10-Q) (10-Q)2026-11-12

Insider report (2)

DocumentTypeFiled
Form 4Form 4 (4)2026-09-16
Form 4Form 4 (4)2026-09-16

Certification (4)

DocumentTypeFiled
EXHIBIT 32.2
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-12
EXHIBIT 31.1
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-12
EXHIBIT 31.2
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-12
EXHIBIT 32.1
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-12

Other (9)

DocumentTypeFiled
FORM 8-KCurrent report (8-K) (8-K)2026-11-12
FORM 8-KCurrent report (8-K) (8-K)2026-10-05
EXHIBIT 10.1
Period 2026-09-30
Material contract / governance (10-Q)2026-11-12
EXHIBIT 10.2
Period 2026-09-30
Material contract / governance (10-Q)2026-11-12

Sources: SEC EDGAR filings (public records); Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

Halted: no resumption notice since 2026-11-09 in our data.

NoticeActionReasonNotice
2026-11-09 9:24 AM ETHaltPending DelistingCIRO notice
2025-12-31 11:30 AM ETResumptionNo reason statedCIRO notice
2025-12-31 9:11 AM ETHaltPending NewsCIRO notice

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Recent

DateTimeEventWebcastSource
2026-11-12No time in the announcementQ3 2026 earnings releaseNo webcast link announcedSEC filing
2026-11-124:30 PM ETQ3 2026 earnings callWebcastSEC filing

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2025-09-04EquityUS$210KUS$210KSEC EDGAR
2024-05-30Option To Acquire, Security To Be AcquiredUS$10.0MUS$10.0MSEC EDGAR
2018-01-12Equity, Option To AcquireUS$13.5MUS$13.5MSEC EDGAR
2015-12-07Equity, Option To AcquireUS$155.3MUS$155.3MSEC EDGAR
2015-08-06Option To AcquireUS$10.0MUS$10.0MSEC EDGAR

Source: SEC EDGAR Form D filings matched on exact issuer name. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
NAVNAVCO Pharmaceuticals Inc.TSXVC$285K0.0%0.0%
EVMTEvome Medical Technologies Inc.TSXVC$301K0.0%0.0%
ARCARCpoint Inc.TSXVC$332K0.0%0.0%
VXLVaxil Bio Ltd.TSXVC$398K-24.1%-35.3%
WAVEWaverley Pharma Inc.TSXVC$540K+100.0%0.0%

The app has the price chart, every filing, private raises and the full peer set for FNT.U.

Open in the app